Company Overview - Chuangguang Medical closed at 17.28 yuan, down 9.15%, with a latest price-to-book ratio of 5.43 and a total market capitalization of 1.483 billion yuan [1] - The company specializes in the research, production, and sales of superconducting MRI systems and special magnets in high-tech fields [1] - Chuangguang Medical has been recognized as a high-tech enterprise, receiving titles such as "Technology Small Giant Enterprise" and "Specialized and Innovative Small Giant Enterprise" at both municipal and national levels [1] Financial Performance - For the third quarter of 2024, the company reported operating revenue of 86.1063 million yuan, a year-on-year decrease of 13.44% [1] - The net profit for the same period was -15,875,336.84 yuan, reflecting a year-on-year decline of 129.77% [1] - The sales gross margin stood at 41.27% [1] Market Sentiment - On March 26, the net outflow of main funds for Chuangguang Medical was 38.8682 million yuan, indicating a trend of outflow over the past five days, totaling 45.3674 million yuan [1] Industry Comparison - The average price-to-earnings (PE) ratio for the industry is 45.14, while Chuangguang Medical's PE (TTM) is -25.58 [2] - The industry median PE is 31.99, and the average price-to-book ratio is 4.84, compared to Chuangguang Medical's 5.43 [2]
辰光医疗收盘下跌9.15%，最新市净率5.43，总市值14.83亿元